Small cell transformation of lung adenocarcinoma in acquired resistance to EGFR-TKI

被引：0
|
作者：
So, Kwang Sup [1 ]
Choi, Yun Jung [1 ]
Kim, Sun Ye [1 ]
Choi, Chang-Min [1 ]
Lee, Jae Cheol [1 ]
Kim, Woo Sung [1 ]
Rho, Jin Kyung [1 ]
机构：
[1] Asan Med Ctr, Seoul, South Korea
来源：
CANCER RESEARCH | 2013年 / 73卷 / 08期
关键词：
D O I：
10.1158/1538-7445.AM2013-4443
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4443
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Noninvasive analysis of acquired resistance to EGFR-TKI
    Kimura, Hideharu
    Nishio, Makoto
    Daito, Tsutomu
    Nishio, Kazuto
    CANCER RESEARCH, 2014, 74 (19)
  • [22] Epithelial-Mesenchymal Transition in EGFR-TKI Acquired Resistant Lung Adenocarcinoma
    Uramoto, Hidetaka
    Iwata, Teruo
    Onitsuka, Takamitsu
    Shimokawa, Hidehiko
    Hanagiri, Takeshi
    Oyama, Tsunehiro
    ANTICANCER RESEARCH, 2010, 30 (07) : 2513 - 2517
  • [23] Targeting FACT complex with CBL0137 to overcome acquired resistance to EGFR-TKI in lung adenocarcinoma
    Sharma, Neelesh
    Dermawan, Josephine
    Purmal, Andrei
    Lindner, Daniel
    Wildey, Gary
    Dowlati, Afshin
    Gudkov, Andrei
    Gurova, Katerina
    Stark, George R.
    CANCER RESEARCH, 2016, 76
  • [24] Overexpression of RhoV Promotes the Progression and EGFR-TKI Resistance of Lung Adenocarcinoma
    Chen, Hongjin
    Xia, Ruixue
    Jiang, Long
    Zhou, Yong
    Xu, Haojun
    Peng, Weiwei
    Yao, Chengyun
    Zhou, Guoren
    Zhang, Yijie
    Xia, Hongping
    Wang, Yongsheng
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [25] DISCOVERY THE NOVEL COMPOUND FOR OVERCOMING EGFR-TKI RESISTANCE IN LUNG ADENOCARCINOMA
    Huang, Kuo-Yen
    Lin, Chung-Chih
    Yang, Shuenn-Chen
    Yang, Pan-Chyr
    RESPIROLOGY, 2018, 23 : 176 - 176
  • [26] MiR-21 overexpression is associated with acquired resistance of EGFR-TKI in non-small cell lung cancer
    Li, Bing
    Ren, Shengxiang
    Li, Xuefei
    Wang, Yongsheng
    Garfield, David
    Zhou, Songwen
    Chen, Xiaoxia
    Su, Chunxia
    Chen, Mo
    Kuang, Peng
    Gao, Guanghui
    He, Yayi
    Fan, Lihong
    Fei, Ke
    Zhou, Caicun
    Schmit-Bindert, Gerald
    LUNG CANCER, 2014, 83 (02) : 146 - 153
  • [27] Efficacy and safety of apatinib plus EGFR-TKI in advanced non-small cell lung cancer with EGFR-TKI resistance (date updated)
    Tian, R.
    Guo, W.
    Guo, Y.
    Zhang, X.
    Zhu, H.
    Shen, F.
    Zhang, X.
    Wang, R.
    Ren, X.
    Li, J.
    Song, X.
    ANNALS OF ONCOLOGY, 2020, 31 : S873 - S873
  • [28] Squamous cell carcinoma transformation from adenocarcinoma as an acquired resistance after the EGFR TKI therapy in (EGFR-mutated) non-small cell lung cancer
    Shinohara, Shinji
    Ichiki, Yoshinobu
    Fukuichi, Yukiko
    Honda, Yohei
    Kanoyama, Masatoshi
    Taira, Akihiro
    Nabe, Yusuke
    Kuwata, Taiji
    Takenaka, Masaru
    Oka, Soichi
    Chikaishi, Yasuhiro
    Hirai, Ayako
    Imanishi, Naoko
    Kuroda, Koji
    Yoneda, Kazue
    Noguchi, Hirotsugu
    Tanaka, Fumihiro
    JOURNAL OF THORACIC DISEASE, 2018, 10 (07) : E526 - E531
  • [29] NOTCH alteration in EGFR-mutated lung adenocarcinoma leads to histological small-cell carcinoma transformation under EGFR-TKI treatment
    Koba, Hayato
    Kimura, Hideharu
    Yoneda, Taro
    Ogawa, Naohiko
    Tanimura, Kota
    Tambo, Yuichi
    Sone, Takashi
    Hosomichi, Kazuyoshi
    Tajima, Atsushi
    Kasahara, Kazuo
    TRANSLATIONAL LUNG CANCER RESEARCH, 2021, 10 (11) : 4161 - +
  • [30] STE029 Overcomes EGFR-TKI Resistance in Human Lung Adenocarcinoma
    Huang, L.
    Zhou, Q.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (12) : S1072 - S1072
12345